Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Prem Subramanian, MD, PhD
Healthcare Professional Chief, Neuro-Ophthalmology
Department of Ophthalmology
University of Colorado School of Medicine
Anschutz Medical Campus
1675 Aurora Court, Mailstop F-731
Aurora, Colorado, United States
Prem S. Subramanian is the Professor of ophthalmology, neurology, and neurosurgery at University of Colorado School of Medicine Anschutz Medical Campus. He specializes in neuro-ophthalmology, with special interest in the treatment of thyroid eye disease, disorders that cause double-vision in adults, as well as orbital and skull base tumors. His clinical practice includes patients with all types of disorders of the optic nerve and orbit. He performs surgery for tumors of the orbit, thyroid exophthalmos, and strabismus.
Dr. Subramanian received his medical degree from Baylor College of Medicine, Houston, Texas followed by residency in ophthalmology from Walter Reed Army Medical Center, Washington, DC and fellowship in neuro-ophthalmology from Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. He has an experience in treating conditions like cranial nerve palsies, double vision, intracranial hypertension, multiple sclerosis, ophthalmology, optic nerve disease, orbital tumors, pseudotumor cerebri, skull base tumors, strabismus, thyroid eye disease, and venous sinus stenosis. His research interests include optic nerve regeneration, traumatic brain injury, and effects of diplopia on quality of life.
Representative Publications:
Treatment Modalities of Thyroid Related Orbitopathy
Optical Coherence Tomography Angiography in Papilledema Compared With Pseudopapilledema
Update on Idiopathic Intracranial Hypertension
Periocular Histiocytoid Carcinoma: Potential Diagnostic Challenges
Related Content
-
Christina H. Choe, MDDr. Christina H. Choe is a board-certifi...
-
Coping Psychologically with Thyroid Eye Diseasehttps://www.youtube.com/watch?v=A-pjRWHj...
-
Clinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presen...Horizon Therapeutics plc today announced...
-
Thyroid Eye Disease Charitable TrustThyroid Eye Disease Charitable Trust (TE...
-
Sensitivity and Responsiveness of the Patient-Reported TED-QOL to Rehabilitative Surgery in Thyroid Eye DiseaseWe tested the sensitivity and responsive...
-
Related Quality of Life Questionnaire Specific to Dysthyroid Ophthalmopathy Evaluated in a Population of Patients Wi...Objective: The aim of this study was to...
-
World Sight Day 2019 – Speaker Event with Susan RobinsonWorld Sight Day 2019 with speaker Susan ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.